Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allosteric modulators
Biotech
Roche pens $2B deal with Atavistik to discover new CVRM drugs
Roche has penned a backloaded $2 billion deal with hematology biotech Atavistik Bio to develop allosteric small molecules for cardiometabolic diseases.
James Waldron
Sep 24, 2026 8:35am
Seyltx gains option to boost cough pipeline with 8 NeurOp drugs
Jun 5, 2025 10:40am
Gain's phase 1 win paves way to prove Parkinson's drug's worth
Aug 29, 2024 10:05am
AbbVie connects with HotSpot for $40M cash
Dec 6, 2022 10:50am
Atavistik Bio snags $60M to tackle metabolic diseases, cancers
Aug 24, 2021 5:23pm
Nimbus vets launch allosteric drugmaker HotSpot with $45M
Jul 17, 2018 9:51am
